potassium chloride has been researched along with 1,4-dihydropyridine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 9 (56.25) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mironneau, C; Mironneau, J; Rakotoarisoa, L; Sayet, I | 1 |
Cuccaro, ML; Jacobs, LS; Lorenson, MY | 1 |
Warbanow, W; Will-Shahab, L | 1 |
Aizawa, T; Komatsu, M; Nagasawa, Y; Takeda, T; Yamada, T; Yokokawa, N | 1 |
Croxton, TL; Farley, LS; Hirshman, CA; Vannier, C | 1 |
Miras-Portugal, MT; Rodriguez-Pascual, F; Torres, M | 1 |
Do Carmo, LG; Jurkiewicz, A; Jurkiewicz, NH; Lafayette, SS; Martini, LC; Nunes, SH; Wanderley, AG | 1 |
Carbone, E; Clementi, F; Codignola, A; Lovallo, M; Pollo, A; Sher, E; Tarroni, P | 1 |
Brenner, HR; Britt, JC; Caroni, P; Rotzler, S | 1 |
Dessy, C; Godfraind, T; Morel, N; Salomone, S | 1 |
Guerrier, P; Krantic, S; Tomkowiak, M | 1 |
Chen, CF; Chen, SY; Liao, JF; Shi, CC; Wang, GJ | 1 |
Doris, PA; Kähönen, M; Kalliovalkama, J; Pekki, A; Pörsti, I; Tolvanen, JP; Voipio, J; Wu, X; Ylitalo, P | 1 |
El Bardai, S; Hamaide, MC; Lyoussi, B; Morel, N; Quetin-Leclercq, J; Wibo, M | 1 |
Arthur, PG; Hool, LC; Viola, HM | 1 |
Rustenbeck, I; Seemann, N; Welling, A | 1 |
16 other study(ies) available for potassium chloride and 1,4-dihydropyridine
Article | Year |
---|---|
Modulation of [3H]dihydropyridine binding by activation of protein kinase C in vascular smooth muscle.
Topics: Aluminum; Animals; Binding Sites; Calcium Channels; Dihydropyridines; Enzyme Activation; Fluorine; Horses; In Vitro Techniques; Isradipine; Membrane Potentials; Membranes; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phorbol Esters; Phosphorylation; Portal Vein; Potassium Chloride; Protein Kinase C; Tritium | 1991 |
Calcium release from pituitary secretory granules: modulation by thiols, disulfides, and dihydropyridine calcium channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Cattle; Cysteine; Cystine; Cytoplasmic Granules; Dihydropyridines; Disulfides; Dithiothreitol; Glutathione; Hydrogen-Ion Concentration; Mercaptoethanol; Nifedipine; Nimodipine; Pituitary Gland; Potassium Chloride; Sulfhydryl Compounds | 1990 |
Altered effect of BAY K 8644 after exposure of the rat aorta to IBMX or Db cAMP.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bucladesine; Cyclic AMP; Dihydropyridines; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Theophylline | 1988 |
Pharmacological characterization of the voltage-dependent calcium channel of pancreatic B-cell.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electrophysiology; Glucose; Insulin; Islets of Langerhans; Male; Mollusk Venoms; Nifedipine; omega-Conotoxin GVIA; Osmolar Concentration; Potassium; Potassium Chloride; Rats; Rats, Inbred Strains; Time Factors | 1989 |
Inhibition of dihydropyridine-sensitive calcium entry in hypoxic relaxation of airway smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bronchi; Calcium; Calcium Channel Blockers; Carbachol; Dihydropyridines; Female; Hypoxia; Male; Muscle Relaxation; Muscle, Smooth; Nifedipine; Potassium Chloride; Swine | 1995 |
Modulation of the dihydropyridine-insensitive Ca2+ influx by 8-bromo-guanosine-3':5'-monophosphate, cyclic (8-Br-cGMP) in bovine adrenal chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Medulla; Animals; Bucladesine; Calcium; Calcium Channels; Cattle; Cells, Cultured; Cyclic GMP; Dihydropyridines; Neomycin; Nerve Tissue Proteins; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Potassium Chloride; Second Messenger Systems; Spider Venoms | 1994 |
Decreased density of binding sites for the Ca2+ channel antagonist [3H]isradipine after denervation of rat vas deferens.
Topics: Animals; Binding Sites; Calcium Channels; Denervation; Dihydropyridines; Isradipine; Male; Muscle Contraction; Potassium Chloride; Rats; Rats, Wistar; Vas Deferens | 1994 |
Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines.
Topics: Autoantibodies; Base Sequence; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Carcinoma, Small Cell; Dihydropyridines; DNA Primers; Fura-2; Humans; Ionomycin; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Molecular Sequence Data; omega-Conotoxin GVIA; Peptides; Potassium Chloride; Serotonin; Terpenes; Thapsigargin; Tritium; Tumor Cells, Cultured | 1993 |
Calcium influx and protein phosphorylation mediate the metabolic stabilization of synaptic acetylcholine receptors in muscle.
Topics: Alkaloids; Animals; Bucladesine; Calcium; Calcium Channels; Cyclic AMP; Dibutyryl Cyclic GMP; Dihydropyridines; Electric Stimulation; Ethers, Cyclic; Kinetics; Male; Marine Toxins; Motor Endplate; Muscle Denervation; Muscles; Okadaic Acid; Organ Culture Techniques; Oxazoles; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Potassium Chloride; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Staurosporine; Synapses; Tetrodotoxin; Time Factors | 1993 |
Activity of dihydrothienopyridine S312 enantiomers on L-type Ca2+ channels in isolated rat aorta and cerebral microvessels.
Topics: Animals; Binding Sites; Brain; Calcium; Calcium Channel Blockers; Dihydropyridines; Male; Muscle, Smooth, Vascular; Potassium Chloride; Rats; Rats, Wistar; Stereoisomerism; Vasoconstriction; Vasodilator Agents | 1993 |
Meiosis reinitiation of mussel oocytes involves L-type voltage-gated calcium channel.
Topics: Animals; Binding Sites; Bivalvia; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Membrane; Dihydropyridines; Dose-Response Relationship, Drug; Ion Channel Gating; Isradipine; Meiosis; Oocytes; Potassium Chloride; Tritium | 1997 |
Vasorelaxant effect of harman.
Topics: Animals; Aorta, Thoracic; Binding, Competitive; Blood Pressure; Brain; Dihydropyridines; Dose-Response Relationship, Drug; Endothelium, Vascular; Harmine; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nitric Oxide; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Serotonin; Vasodilation | 2000 |
Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Digoxin; Dihydropyridines; Enalapril; Heart; Hypertension; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Organ Size; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Tunica Media | 2000 |
Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel.
Topics: Animals; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Diterpenes; Furans; Ileum; In Vitro Techniques; Isradipine; Male; Membranes; Muscle Contraction; Muscle, Smooth; Potassium Chloride; Radioligand Assay; Rats; Rats, Wistar; Vasodilator Agents; Verapamil | 2004 |
Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes.
Topics: Actins; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocytes, Cardiac; NAD; Patch-Clamp Techniques; Potassium Chloride; Superoxides | 2009 |
The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Connexins; Dihydropyridines; Gap Junction delta-2 Protein; Glucose; Insulin Secretion; Insulin-Secreting Cells; Ion Channel Gating; Mefloquine; Mice; Nisoldipine; Potassium Chloride; Tolbutamide | 2018 |